J. Goldman & CO LP Intra Cellular Therapies, Inc. Call Options Transaction History

J. Goldman & CO LP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $8.14 Million - $12.9 Million	175,500 New	175,500 $12.6 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $2.51 Million - $3.05 Million	45,900 New	45,900 $2.91 Million
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $1.83 Million - $2.94 Million	-47,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $686,400 - $1.04 Million	-19,500 Reduced 29.19%	47,300 $2.48 Million
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $1.56 Million - $2.15 Million	66,800 New	66,800 $2.12 Million
Q3 2020 Nov 16, 2020	SELL	$17.61 - $31.86 $1.98 Million - $3.58 Million	-112,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $1.61 Million - $3 Million	112,500 New	112,500 $2.89 Million
Q3 2019 Nov 14, 2019	SELL	$7.47 - $14.03 $298,800 - $561,200	-40,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $681,600 - $914,560	-64,000 Reduced 61.54%	40,000 $519,000
Q1 2019 May 14, 2019	BUY	$10.9 - $14.09 $1.13 Million - $1.47 Million	104,000 New	104,000 $1.27 Million
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $2.77 Million - $4.65 Million	-182,600 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $750,602 - $883,154	52,600 Added 40.46%	182,600 $2.64 Million
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $1.4 Million - $2.87 Million	130,000	130,000 $2.05 Million

380

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.